# OnCo record gilles-salles (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/gilles-salles/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "gilles-salles" ;
  schema:name "Gilles Salles"@en ;
  schema:description "Led PRIMA, which established rituximab maintenance in follicular lymphoma, and co-chaired POLARIX in DLBCL."@en ;
  schema:url <https://onco.cc/people/gilles-salles/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Gilles_Salles>, <https://orcid.org/0000-0002-9541-8666> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Salles%20G%5BAuthor%5D%20lymphoma> ;
  onco:tag "lymphoma", "trialist", "lysa" ;
  schema:jobTitle "Chief, Lymphoma Service, Memorial Sloan Kettering Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:companies <https://onco.cc/companies/lysa/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/polarix/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-polarix-polatuzumab-rchp-nejm-2022/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .